HP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
HP is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock has a neutral-to-mixed setup: technicals are not confirming a breakout, options sentiment is only mildly constructive, and recent analyst updates are mostly positive but not uniformly bullish. I would not buy aggressively at this pre-market price; I would wait for a cleaner trend confirmation or a better entry.
HP is trading pre-market around 38.84, close to pivot support at 38.667 and below the first resistance at 39.937. RSI_6 at 52.675 is neutral, so momentum is not stretched in either direction. MACD histogram is -0.117 and still below zero, though negative pressure is easing. Moving averages are converging, which usually signals an indecisive trend rather than a strong directional move. The near-term setup suggests the stock is consolidating and has not yet proven a durable upside breakout. The provided pattern-based trend also points to only a small next-day gain and weakness over the next month.
Analysts have been raising price targets across the board, with several firms maintaining Buy/Overweight/Positive views and targets generally in the low-to-mid $40s. Goldman Sachs, BofA, Piper Sandler, Susquehanna, Barclays, and Evercore all highlighted improved oilfield activity, tighter supply conditions, and a more favorable multi-year upstream spending backdrop. News also shows FY 2025 revenue growth of 35.9%, which is a strong top-line trend. The company’s U.S.-focused business mix and manageable customer concentration are also supportive. No recent congress trading data was found, and no politician/influential figure trades were reported.
Insider selling has increased sharply over the last month, and hedge funds have also been selling heavily over the last quarter. Goldman Sachs remains Neutral, and Morgan Stanley is still Underweight, showing that Wall Street is not fully aligned on the upside case. Net income fell to $93.97 million despite strong revenue growth, indicating margin pressure and weaker profitability. Technical momentum is not strong enough to justify an impatient entry, especially with the stock hovering near resistance and the short-term pattern suggesting potential weakness over the next month.
Latest reported quarter/period data points to FY 2025 rather than a single quarterly beat: revenue rose 35.9% to $3.75 billion, which is a strong growth trend, but net income declined to $93.97 million, showing that higher sales are not yet translating into stronger earnings. This is a good top-line story, but profitability remains under pressure. The company’s debt-to-equity ratio of 0.76 is moderate and less conservative than some peers, but still manageable. Overall, financial growth is positive on revenue, weaker on earnings quality.
Recent analyst sentiment has improved, with multiple target raises over the last two months. BofA is Buy at $44, Piper Sandler is Overweight at $43, Susquehanna is Positive at $43, Barclays is Overweight at $47, and Evercore upgraded to Outperform with a $43 target. Goldman Sachs is more cautious at Neutral with a $41 target, and Morgan Stanley remains Underweight at $39. Wall Street’s pros view is that H&P benefits from improving oilfield activity, a better oil price backdrop, and a multi-year capex cycle. The cons view is that profitability is still pressured, and some firms remain cautious on the pace of upside. Net takeaway: analyst trends are improving, but the consensus is not strongly bullish enough to make HP a clear buy today.
